Oral Rigosertib Combined with Azacitidine as First-Line Therapy in Patients with Higher-Risk MDS: Report of a Phase 2 Study

Download Transcript Download Audio

MediCom Worldwide, Inc. Links

ManagingAML.com | ManagingMyeloma.com | ManagingMPN.com | ManagingLymphoma.com | PracticalOncologist.com | PracticalHematologist.com | ManagingCVD.com | ManagingSCD.com | MediComWorldwide.com